EE327 Cost-Effectiveness Analysis of Cemiplimab for Patients With Advanced Non-Small Cell Lung Carcinoma in Spain
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.573
https://www.valueinhealthjournal.com/article/S1098-3015(22)02777-2/fulltext
Title :
EE327 Cost-Effectiveness Analysis of Cemiplimab for Patients With Advanced Non-Small Cell Lung Carcinoma in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02777-2&doi=10.1016/j.jval.2022.09.573
First page :
Section Title :
Open access? :
No
Section Order :
10102